Jane Edwards
Lockheed Martin has secured rights to use B-Temia’s Dermoskeleton technology platform in products intended for military, first responder and industrial applications under a license agreement with the latter.
Dermoskeleton works to prevent overstress on the lower legs and back in order to increase the user’s mobility and capacity to carry load, Lockheed said Tuesday.
Glenn Kuller, advanced and special programs vice president at Lockheed’s missiles and fire control, said the company will use B-Temia’s Dermoskeleton to build up the agility and loadbearing capacity of Lockheed’s FORTIS industrial exoskeleton as well as address limitations in exoskeleton devices for first responders and military personnel.
FORTIS works to transfer the weight of the load from the user’s body to the ground to increase the user’s endurance and strength.
